$PTCO
PetroGas Co

2023 Q2 Form 10-K Financial Statement

#000164033423001250 Filed on July 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.65K $43.95K
YoY Change -28.52% -99.97%
Operating Profit -$10.65K -$43.95K
YoY Change -28.52% -99.96%
Interest Expense $14.62K $58.63K
YoY Change 0.0% 2.78%
% of Operating Profit
Other Income/Expense, Net $14.62K $58.63K
YoY Change 0.0% 2.78%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$25.27K -$102.6K
YoY Change -14.4% -99.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 21.05M shares 21.05M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.20K
YoY Change 57.98%
Accrued Expenses $245.4K
YoY Change 31.38%
Deferred Revenue
YoY Change
Short-Term Debt $320.00
YoY Change 0.0%
Long-Term Debt Due $269.4K
YoY Change 0.0%
Total Short-Term Liabilities $669.8K $644.5K $644.5K
YoY Change 17.21% 18.93% 18.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $83.58K
YoY Change 0.0%
Total Long-Term Liabilities $83.58K $83.58K $83.58K
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $669.8K $644.5K $644.5K
Total Long-Term Liabilities $83.58K $83.58K $83.58K
Total Liabilities $753.4K $728.1K $728.1K
YoY Change 15.01% 16.4% 16.4%
SHAREHOLDERS EQUITY
Retained Earnings -$142.2M -$142.2M
YoY Change 0.07% 0.07%
Common Stock $21.05K $21.05K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$753.4K -$728.1K -$728.1K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$25.27K -$102.6K
YoY Change -14.4% -99.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.00K -$33.60K
YoY Change -39.76% 3.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $10.00K $33.60K
YoY Change -39.76% 3.28%
NET CHANGE
Cash From Operating Activities -$10.00K -$33.60K
Cash From Investing Activities
Cash From Financing Activities $10.00K $33.60K
Net Change In Cash $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$10.00K -$33.60K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
21048 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141452414 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142201585 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-728123 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
21048 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-102575 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
0 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
140000000 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
34275 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
101174 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
67574 usd
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
219768 usd
CY2022Q1 ptco Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
42683 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001609258
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21048440 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21048440 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21048440 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-196409
CY2023 dei Entity Registrant Name
EntityRegistrantName
PETROGAS COMPANY
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1153516
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Post Oak Boulevard
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4100
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77056
CY2023 dei City Area Code
CityAreaCode
806
CY2023 dei Local Phone Number
LocalPhoneNumber
375-3338
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
322 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
219768 usd
CY2023Q1 ptco Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
42683 usd
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
393085 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21048440 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
322 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2023Q1 us-gaap Commercial Paper
CommercialPaper
6962 usd
CY2022Q1 us-gaap Commercial Paper
CommercialPaper
6962 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21048440 shares
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141452414 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142099010 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-625548 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
43900 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
140034275 usd
CY2023 us-gaap Other Expenses
OtherExpenses
58625 usd
CY2022 us-gaap Other Expenses
OtherExpenses
57040 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-102575 usd
CY2023 ptco Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022 ptco Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-12.63
CY2023 ptco Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
21048440 shares
CY2022 ptco Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
11095016 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-535233 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
140000000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
1000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-140091315 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-625548 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-728123 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-102575 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-140091315 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
140000000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10350 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1742 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
58625 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
57040 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33600 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32533 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
33600 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
32533 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33600 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32533 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 ptco Conversion Of Convertible Notes Into Common Shares
ConversionOfConvertibleNotesIntoCommonShares
0 usd
CY2022 ptco Conversion Of Convertible Notes Into Common Shares
ConversionOfConvertibleNotesIntoCommonShares
1000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known. Any estimates during the period have had an immaterial effect on earnings.</p>
CY2023Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
83580 usd
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
174000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
31558 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 ptco Reverse Stock Split Description
ReverseStockSplitDescription
common stock on a basis of up to eighty (80) old shares for one (1) new share of common stock
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21048440 shares
CY2021 us-gaap Officers Compensation
OfficersCompensation
105000000 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
101174 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
67574 usd

Files In Submission

Name View Source Status
0001640334-23-001250-index-headers.html Edgar Link pending
0001640334-23-001250-index.html Edgar Link pending
0001640334-23-001250.txt Edgar Link pending
0001640334-23-001250-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptco-20230331.xsd Edgar Link pending
ptco_10k.htm Edgar Link pending
ptco_ex311.htm Edgar Link pending
ptco_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
ptco-20230331_cal.xml Edgar Link unprocessable
ptco-20230331_def.xml Edgar Link unprocessable
ptco-20230331_lab.xml Edgar Link unprocessable
ptco-20230331_pre.xml Edgar Link unprocessable
ptco_10k_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable